Our Internal Medicine residents made a strong showing at Digestive Disease Week (DDW) 2026, held from May 2–5, 2026, at McCormick Place in Chicago, Illinois. As the premier global congress for healthcare professionals in gastroenterology, hepatology, endoscopy, and gastrointestinal surgery, DDW brings together top researchers and clinicians to share leading-edge advancements in digestive health.
Our participating residents presented original clinical research and collaborated directly with Gastroenterology fellows from Riverside Community Hospital.
Resident Presentations
- Regis Lee, DO
- Impact of GLP-1 Receptor Agonist Therapy on Esophageal Outcomes in Lean and Non-Lean Patients with GERD
- Resmetirom vs. Semaglutide in MASH: A Real-World Assessment of Clinical Outcomes, Safety Events, and Biochemical Trajectories
- Nishani Wickramarachchi, DO
- Improved Clinical Outcomes in Ulcerative Colitis Using Statins
- Rowena Feng, DO
- Beyond Sodium: Low Serum Chloride as a Novel Predictor of Adverse Outcomes in Cirrhosis
Beyond presenting data to an international audience, our residents network and work alongside Riverside Community Hospital GI fellows, strengthening the work between our core residency training and subspecialty fellowship success.
Congratulations to Dr. Feng, Dr. Wickramarachchi, and Dr. Lee for advancing clinical knowledge on a global stage.
IM Riverside 
Leave a comment